Joakim Nyberg, Ph.D.

Chief Technology Officer


  • Co-founded Pharmetheus in 2012, serving as Chief Technology Officer, part of the executive leadership team, leading the Enabler department
  • Expertise includes pharmacometrics, trial design, and systems development
  • Experience as Researcher at Uppsala University, Sweden, where he has a part-time position to perform pharmacometric research, primarily by supervision of Ph.D. students. Previously worked as System Developer at B&M Systemutveckling AB, Sweden
  • M.Sc. in Engineering Physics (2006) and Ph.D. in Pharmaceutical Biosciences (2011) from Uppsala University, Sweden
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Using forest plots to interpret covariate effects in pharmacometric modelsProperties of the full random-effect modeling approach with missing covariate dataA framework for prediction of progression free survival based on modelling of sub-endpointsChecklists and best practices to support the informed use of Forest plots to illustrate the impact of covariates in pharmacometric modelsExposure–Response Analyses for the MET Inhibitor Tepotinib Including Patients in the Pivotal VISION Trial: Support for Dosage RecommendationsAn Introduction to the Full Random Effects ModelGeneralized FOCE with PumasA Quantitative Approach to the Choice of Number of Samples for Percentile Estimation in Bootstrap and Visual Predictive Check AnalysesSensitivity of Pegfilgrastim Pharmacokinetic and Pharmacodynamic Parameters to Product Differences in Similarity StudiesModel Based Support to Biosimilarity Assessment Planning – A Case Study of PegfilgrastimImplicit and Efficient Handling of Missing Covariate Information Using Full Random Effects Modelling